Immuneering Corporation - Class A Common Stock (IMRX)
Seasonality Analysis
Immuneering Corporation - Class A Common Stock Annual Seasonality Statistics
Immuneering Corporation - Class A Common Stock Monthly Seasonality Performance
| Month | Avg Return | Win Rate | Strength |
|---|---|---|---|
| January WORST | -19.75% | Very Weak | |
| February | -2.23% | Weak | |
| March | 7.53% | Moderate | |
| April | -15.10% | Weak | |
| May | -4.87% | Very Weak | |
| June | 29.22% | Very Strong | |
| July | 7.85% | Weak | |
| August | 13.54% | Weak | |
| September BEST | 43.19% | Very Strong | |
| October | -5.23% | Very Weak | |
| November | -7.88% | Weak | |
| December | -11.61% | Very Weak |
Immuneering Corporation - Class A Common Stock 2026 vs Historical Pattern
Immuneering Corporation - Class A Common Stock Interactive Seasonality Chart
Immuneering Corporation - Class A Common Stock Pattern Scanner
Immuneering Corporation - Class A Common Stock Seasonal Historical Performance
About Immuneering Corporation - Class A Common Stock (IMRX) Seasonality
Immuneering Corporation - Class A Common Stock (IMRX) has been analyzed using 5 years of historical data to identify seasonal patterns. Classified under Stocks, Immuneering Corporation - Class A Common Stock shows distinct seasonal tendencies based on historical data.
The strongest month for Immuneering Corporation - Class A Common Stock is historically September, with an average return of 43.19% and a win rate of 80%. Conversely, January tends to be the weakest month, averaging -19.75% return.
Looking at the full calendar year, Immuneering Corporation - Class A Common Stock has an average annual return of 34.66% with an overall monthly win rate of 45.8%. Out of 12 months, 5 typically show positive average returns.
The seasonal pattern for Immuneering Corporation - Class A Common Stock has a consistency score of 41.2 (Poor), based on 6 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.
Immuneering Corporation - Class A Common Stock Seasonality FAQ
What is the best month to buy Immuneering Corporation - Class A Common Stock (IMRX)?
Historically, September has been the best month for Immuneering Corporation - Class A Common Stock, with an average return of 43.19% and a win rate of 80%. However, past performance does not guarantee future results.
What is the worst month for Immuneering Corporation - Class A Common Stock (IMRX)?
Based on historical data, January has been the weakest month for Immuneering Corporation - Class A Common Stock, with an average return of -19.75%. This is a historical observation and does not guarantee future results.
How reliable is IMRX seasonality data?
The seasonality analysis for Immuneering Corporation - Class A Common Stock is based on 5 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.
How can I use Immuneering Corporation - Class A Common Stock seasonality in my trading?
Use Immuneering Corporation - Class A Common Stock (IMRX) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.